|
Validity and Reliability of the Thai Version of Rome IV
Diagnostic Questionnaires for Pediatric Gastrointestinal
Disorders
Siajunboriboon S, MD1, Ngoenmak T, MD2, Tanpowpong P, MD, MPH1, Sarawit M, PhD3, Treepongkaruna S, MD1
|
S1 |
|
|
Prevalence of Helicobacter pylori Infection in Water Trash
Collectors of Bangkok Metropolitan Administration
Chaleerin A, MD1, Boonsirichan R, MD1
|
S5 |
|
|
7-Day High-Dose Proton Pump Inhibitor versus 10-day
Standard Concomitant Therapy for Helicobacter pylori
Eradication in Thai Patients: A Randomized Controlled Trial
Rojsanga W, MD1, Chanpiwat K, MD1, Bunchorntavakul C, MD1
|
S12 |
|
|
Gastric Cancer in Thai Patients, Helicobacter pylori and
Human Epidermal Growth Factor Receptor 2 (HER2) Status
Ongprakobkul C, MD1, Kwankajonwong N, MD1, Werawatganon D, MD1, Klaikaew N, MD2, Rerknimitr R, MD3
|
S18 |
|
|
Comparison of Survival Times of Diffuse Large B-Cell
Lymphoma Patients with or without Gastrointestinal
Involvement
Pulputtapong J, MD1, Sripongpun P, MD1, Chamroonkul N, MD1, Kongkamol C, MD2, Julamanee J, MD1,
Lekhakula A, MD1
|
S23 |
|
|
Prevalence of Gastrointestinal Findings Responsible for
Anemia in Different Groups of Anemic Patients:
Retrospective Study from a Large Tertiary Hospital
Thepwiwatjit S, MD1, Aussavavirojekul P, MD1, Manomaiwong N, MD1, Sriprayoon T, MD1, Pongprasobchai S, MD2
|
S30 |
|
|
Using Nutrition Risk Scores to Predict Hospital Length of
Stay in Mild Acute Pancreatitis: A Prospective Cohort Study
Kittikundecha T, MD1, Lakananurak N, MD2, Rerknimitr R, MD3
|
S38 |
|
|
Predictive Factors for Survival Time of 273 Inoperable Hilar
Cholangiocarcinoma Patients: Disease Registry Analyses
Srikhajonjit S, MD1, Mairiang P, MD1, Mairiang E, MD2, Sawadpanitch K, MD1, Sangchan A, MD1,
Sukeepaisarnjaroen W, MD1, Chunlertrith K, MD1
|
S43 |
|
|
Adefovir, Tenofovir and Entecavir Renal Abnormality
in Chronic Hepatitis B Patients
Tanwandee T, MD1, Chainuvati S, MD1, Seansawat K, MD1
|
S50 |
|
|
Lamivudine Switching after Undetectable HBV DNA is
Associated with High Rate of Virological Rebound in
Entecavir-treated Chronic Hepatitis B Patients
Chainuvati S, MD1, Yingcharoen K, MD1, Tanwandee T, MD1
|
S56 |
|
|
HBsAg Quantitation Cannot Predict Virological Flare in
Chronic Inactive Hepatitis B Infection
Chainuvati S, MD1, Kitikomonkun P, MD1, Tanwandee T, MD1
|
S61 |
|
|
Clinical Outcome and Prognosis of Acute-on-Chronic Liver
Failure: Experience from a Tertiary Care Center
Sirimongkolkasem J, MD1,2, Teerasarntipan T, MD1,2, Wongkarnjana A, MD1,2, Thanapirom K, MD1,2, Chaiteerakij R, MD, PhD1,2,
Phathong C, MA1, Komolmit P, MD1,2, Tangkijvanich P, MD, PhD3, Treeprasertsuk S, MD, PhD1,2
|
S66 |
|
|
Diagnostic Performance and Correlation of Hepatitis C
Virus Core Antigen Compared with Hepatitis C Virus RNA
Suttichaimongkol T, MD1, Saikong W, MD1, Sukeepaisarnjaroen W, MD1,2
|
S75 |
|
|
The Natural History of Hepatitis C Viral Infection and HCV
Genotypic Distribution in Thai Hemophilia Patients at
Siriraj Hospital
Chuenjitkulthaworn T, MD1, Bandidniyamanon W, MEcon3, Ruchutrakool T, MD2, Chainuvati S, MD3
|
S81 |
|
|
Incidence and Factors Associated with Undiagnosed
Diabetes by Fasting Plasma Glucose in Cirrhotic Patients
Shinrattanaroj P, MD1, Pornthisarn B, MD1, Vilaichone R, MD, PhD1,3, Chonprasertsuk S, MD MSc1, Kanokwanvimol A, MD1,
Bhanthumkomol P, MD1, Chotivitayatarakorn P, MD1, Anthanont P, MD2, Siramolpiwat S, MD, MSc1,3
|
S86 |
|
|
Change of Plasma Renin-Aldosterone and
Paracentesis-Induced Circulatory Dysfunction after
Non Large-Volume Paracentesis in Different MELD Cirrhotic
Patients
Songlin T, MD1, Sethasine S, MD1
|
S92 |
|
|
Prognostic Score Predicting Overall Survival of Patients
with Intermediate Stage of Hepatocellular Carcinoma after
Transcatheter Transarterial Chemoembolization
Jarupongprapa S, MD1, Nimanong S, MD1, Chainuvati S, MD1, Charatcharoenwitthaya P, MD1, Tanwandee T, MD1,
Srisajjakul S, MD2, Chotiyaputta W, MD1
|
S100 |
|
|
Survival Outcomes of Metastatic/Unresectable
Hepatocellular Carcinoma in Patients Treated with
Sorafenib
Chantharasamee J, MD1, Chotiyaputta W, MD2, Nimmannit A, MD3, Techawatanawanna S, MD1
|
S107 |
|
|
Triple-Dose vs. Split-Dose PEG-ELS Bowel Preparation
before Colonoscopy in Constipated Patients: A Prospective,
Endoscopist-Blinded, Randomized Controlled Trial
Chancharoen A, MD1, Mairiang P, MD2, Sawadpanich K, MD1, Suttichaimongkol T, MD1, Kunyakham W, MD3,
Limpapanasit U, MD4, Chansuk N, MD4, Borntrakulpipat S, MD5
|
S113 |
|
|
A Randomized Controlled Trial Comparing Polyethylene
Glycol Solution Plus Prucalopride with Polyethylene Glycol
Solution Alone on the Efficacy of Bowel Preparation for
Colonoscopy
Kerdsin S, MD1, Sutthivana C, MD1, Suphanchaimat R, MD2,3, Thammatacharee N, PhD4
|
S120 |
|
|
Impact of Prophylaxis Percutaneous Endoscopic
Gastrostomy on the Survival Rate of Patients with
Nasopharyngeal Cancer Stage II to IV Undergoing Definitive
Concurrent Chemo-Radiation Therapy
Pattarapuntakul T, MD1, Chamroonkul N, MD2, Sripongpan P, MD2, Netinatsuton N, MD1, Tangthongkum M, MD3,
Ovartlarnporn B, MD1
|
S124 |
|
|
Percutaneous Endoscopic Gastrostomy in Pediatric Patients:
Experience of 201 Cases in a Tertiary-Care Hospital
Lertudomphonwanit C, MD1, Butsriphum N, RN1, Prabpram W, RN1, Sumritsopak R, RN1, Tanpowpong P, MD, MPH1,
Treepongkaruna S, MD1
|
S130 |
